Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2003.
Current awareness in geriatric psychiatry.
International Journal of Geriatric Psychiatry,
Vol. 18,
Issue. 7,
p.
661.
Rao, Tadimeti S
Reid, Richard T
Correa, Lucia D
Santori, Emily M
Gardner, Michael F
Sacaan, Aida I
Lorrain, Daniel
and
Vernier, Jean-Michel
2003.
In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
Brain Research,
Vol. 986,
Issue. 1-2,
p.
71.
Ley, L.
and
Herdegen, T.
2004.
Brain Damage and Repair.
p.
589.
Mattson, Mark P.
2004.
Pathways towards and away from Alzheimer's disease.
Nature,
Vol. 430,
Issue. 7000,
p.
631.
Lane, Roger M.
Kivipelto, Miia
and
Greig, Nigel H.
2004.
Acetylcholinesterase and Its Inhibition in Alzheimer Disease.
Clinical Neuropharmacology,
Vol. 27,
Issue. 3,
p.
141.
Selkirk, S M
2004.
Gene therapy in clinical medicine.
Postgraduate Medical Journal,
Vol. 80,
Issue. 948,
p.
560.
Morton, A. Jennifer
Hunt, Mark J.
Hodges, Angela K.
Lewis, Paul D.
Redfern, Amanda J.
Dunnett, Stephen B.
and
Jones, Lesley
2005.
A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease.
European Journal of Neuroscience,
Vol. 21,
Issue. 4,
p.
855.
Barker, Warren W
Luis, Cheryl
Harwood, Dylan
Loewenstein, David
Bravo, Marina
Ownby, Ray
and
Duara, Ranjan
2005.
The Effect of a Memory Screening Program on the Early Diagnosis of Alzheimer Disease.
Alzheimer Disease & Associated Disorders,
Vol. 19,
Issue. 1,
p.
1.
Ropacki, Susan A.
and
Jeste, Dilip V.
2005.
Epidemiology of and Risk Factors for Psychosis of Alzheimer’s Disease: A Review of 55 Studies Published From 1990 to 2003.
American Journal of Psychiatry,
Vol. 162,
Issue. 11,
p.
2022.
Eskander, Mariam F.
Nagykery, Nicholas G.
Leung, Elaine Y.
Khelghati, Bahiyyih
and
Geula, Changiz
2005.
Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Brain Research,
Vol. 1060,
Issue. 1-2,
p.
144.
Jacobsen, J. Steven
Reinhart, Peter
and
Pangalos, Menelas N.
2005.
Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer’s disease.
NeuroRX,
Vol. 2,
Issue. 4,
p.
612.
Zimmermann, Martina
Borroni, Barbara
Cattabeni, Flaminio
Padovani, Alessandro
and
Di Luca, Monica
2005.
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
Neurobiology of Disease,
Vol. 19,
Issue. 1-2,
p.
237.
Babiloni, Claudio
Cassetta, Emanuele
Dal Forno, Gloria
Del Percio, Claudio
Ferreri, Florinda
Ferri, Raffaele
Lanuzza, Bartolo
Miniussi, Carlo
Moretti, Davide V.
Nobili, Flavio
Pascual-Marqui, Roberto D.
Rodriguez, Guido
Luca Romani, Gian
Salinari, Serenella
Zanetti, Orazio
and
Rossini, Paolo M.
2006.
Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders.
NeuroImage,
Vol. 31,
Issue. 4,
p.
1650.
Thevis, Mario
Wilkens, Frauke
Geyer, Hans
and
Schänzer, Wilhelm
2006.
Determination of therapeutics with growth‐hormone secretagogue activity in human urine for doping control purposes.
Rapid Communications in Mass Spectrometry,
Vol. 20,
Issue. 22,
p.
3393.
Liesener, André
Perchuc, Anna-Maria
Schöni, Reto
Schebb, Nils Helge
Wilmer, Marianne
and
Karst, Uwe
2007.
Screening of acetylcholinesterase inhibitors in snake venom by electrospray mass spectrometry.
Pure and Applied Chemistry,
Vol. 79,
Issue. 12,
p.
2339.
Vieira, Ivo J.C.
Medeiros, Walter L.B.
Monnerat, Cecilia S.
Souza, Jucimar J.
Mathias, Leda
Braz-Filho, Raimundo
Pinto, Angelo C.
Sousa, Priscila M.
Rezende, Claudia M.
and
Epifanio, Rosângela De A.
2008.
Two fast screening methods (GC-MS and TLC-ChEI assay) for rapid evaluation of potential anticholinesterasic indole alkaloids in complex mixtures.
Anais da Academia Brasileira de Ciências,
Vol. 80,
Issue. 3,
p.
419.
Geula, Changiz
Nagykery, Nicholas
Nicholas, Alexander
and
Wu, Chuang-Kuo
2008.
Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease.
Journal of Neuropathology & Experimental Neurology,
Vol. 67,
Issue. 4,
p.
309.
Barten, Donna M.
and
Albright, Charles F.
2008.
Therapeutic Strategies for Alzheimer’s Disease.
Molecular Neurobiology,
Vol. 37,
Issue. 2-3,
p.
171.
Epis, Roberta
Marcello, Elena
Gardoni, Fabrizio
Longhi, Annalisa
Calvani, Menotti
Iannuccelli, Maurizio
Cattabeni, Flaminio
Canonico, Pier L.
and
Di Luca, Monica
2008.
Modulatory effect of acetyl-l-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
European Journal of Pharmacology,
Vol. 597,
Issue. 1-3,
p.
51.
Sofuoglu, Mehmet
and
Mooney, Marc
2009.
Cholinergic Functioning in Stimulant Addiction.
CNS Drugs,
Vol. 23,
Issue. 11,
p.
939.